Updated:
Genome Medical Services
Genome Medical Services is a other based in San Francisco, founded 2016; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Genome Medical Services
The leading provider of telehealth genetic services. Access expert guidance, accelerate diagnoses and improve rare disease care.
General information
Firm type
other
Year founded
2016
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Jill Davies
Chief Executive Officer
Mark Sylvester
Chief Financial Officer
Kiley Johnson
Chief Clinical Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Genome Medical Services?
Genome Medical Services is a privately held operational company, not an investment manager. CEO Jill Davies and the leadership team run the business; capital allocation decisions are internal (per the firm's website).
Does Genome Medical Services manage external capital?
No. The company operates as a telehealth service provider, generating revenue through patient consultations and partnerships with health systems, labs, and life sciences organizations (per the firm's website). It does not claim to manage any investment fund.
How does Genome Medical source its clients?
Patients can book a telehealth genetic counseling appointment directly. The company also partners with hospitals, health systems, life sciences companies, and genetic testing laboratories to provide services to their patients (per the firm's website).
Is Genome Medical Services structured as a single family office or an operating company?
It is an operating company, not a family office. The firm describes itself as "the leading provider of telehealth-enabled genetic services" and does not report any family-office activities in its public materials.
What investment stages does Genome Medical Services typically target?
None. Genome Medical is a healthcare services business, not an investment firm. It does not make venture or growth-stage investments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: